Risk-benefit considerations for antirheumatic drug use in pregnancy, breastfeeding, and male preconception: expert perspectives.
- DOI
- 10.1016/j.ero.2026.03.002
- Published
- 2026 Jun
- Container
- EULAR rheumatology open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ero.2026.03.002,
title = {Risk-benefit considerations for antirheumatic drug use in pregnancy, breastfeeding, and male preconception: expert perspectives.},
author = {Pluma A and Rüegg L and Hamroun S and Cecchi I and Finckh A and Meissner Y and Förger F},
year = {2026},
journal = {EULAR rheumatology open},
doi = {10.1016/j.ero.2026.03.002},
url = {https://doi.org/10.1016/j.ero.2026.03.002}
}RIS
TY - JOUR TI - Risk-benefit considerations for antirheumatic drug use in pregnancy, breastfeeding, and male preconception: expert perspectives. AU - Pluma A AU - Rüegg L AU - Hamroun S AU - Cecchi I AU - Finckh A AU - Meissner Y AU - Förger F PY - 2026 JO - EULAR rheumatology open DO - 10.1016/j.ero.2026.03.002 UR - https://doi.org/10.1016/j.ero.2026.03.002 ER -
APA
A, P., L, R., S, H., I, C., A, F., Y, M., & F, F. (2026). Risk-benefit considerations for antirheumatic drug use in pregnancy, breastfeeding, and male preconception: expert perspectives.. EULAR rheumatology open. https://doi.org/10.1016/j.ero.2026.03.002
Source records
- pubmed · retrieved 2026-09-27T07:48:40.411Z